Robert Brendza is the Director of Pharmacology at Prothena Corporation plc, where they leverage over 20 years of experience in in vivo science, encompassing basic and pharmaceutical research. Previously, they held significant roles at Nitrase Therapeutics and Elan Pharmaceuticals, contributing to the development of models for Alzheimer’s and Parkinson’s disease therapies. Brendza earned a Ph.D. in Molecular, Cellular, and Developmental Biology from Indiana University Bloomington and a B.S. in Biological Sciences from Carnegie Mellon University. Their expertise in rodent models and project management has made them a key resource in drug development and target validation efforts.
This person is not in the org chart
This person is not in any teams
This person is not in any offices